Marhureeta Achari
Neurology · Houston, TXNPI 1588689442
Payments from drug & device makers
Across 177 payments — averaging $336.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$47K
- Lilly USA, LLC$6K
- SK Life Science, Inc.$1K
- Amneal Pharmaceuticals LLC$543
- Pfizer$448
- Medtronic$369
- plus $3K from 27 others
What the payments were for
- Consulting fees$30,31351%
- Speaking & faculty fees$9,87517%
- Travel & lodging$12,56321%
- Food & beverage$6,86412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 16 | $47,475 |
| Lilly USA, LLC | 36 | $6,497 |
| SK Life Science, Inc. | 28 | $1,166 |
| Amneal Pharmaceuticals LLC | 20 | $543 |
| Pfizer | 9 | $448 |
| Medtronic(2 entities) | 4 | $369 |
| AbbVie(2 entities) | 10 | $285 |
| UCB, Inc. | 5 | $272 |
| Boston Scientific | 2 | $244 |
| Abbott | 1 | $196 |
| Otsuka America Pharmaceutical, Inc. | 5 | $187 |
| Neuronetics, Inc. | 1 | $177 |
| Kyowa Kirin, Inc. | 3 | $158 |
| EMD Serono, Inc. | 3 | $153 |
| Amgen(2 entities) | 5 | $150 |
| Greenwich Biosciences, Inc. | 1 | $131 |
| Grifols USA, LLC | 1 | $124 |
| Eisai Inc. | 2 | $123 |
| Akcea Therapeutics, Inc. | 1 | $115 |
| Novo Nordisk | 1 | $111 |
| Johnson & Johnson | 1 | $101 |
| MDD US Operations, LLC | 1 | $99 |
| Lundbeck LLC | 1 | $95 |
| GE HealthCare | 4 | $68 |
| Tonix Medicines, Inc. | 3 | $61 |
| Biogen | 3 | $50 |
| Aucta Pharmaceuticals, Inc. | 3 | $47 |
| Microtransponder, Inc. | 1 | $46 |
| Sunovion Pharmaceuticals Inc. | 2 | $45 |
| Zyla Life Sciences, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KISUNLA$12,744
- AMYVID$3,000
- EMGALITY$1,579
- XCOPRI$366
- INFINITY$196
- NEUROSTAR TMS THERAPY SYSTEM$177
- NURTEC ODT$146
- Epidiolex$131
- NOURIANZ$125
- GENERAL DBS$125
- Gamunex-C$124
- REXULTI$122
- INTELLIS ADAPTIVESTIM$122
- SPECTRA WAVEWRITER$119
- CREXONT$115
- TEGSEDI$115
- Ozempic$111
- RYTARY$109
- Mavenclad$105
- DALVANCE$103
How this compares
$59,615 in reported general payments places this provider in the 80th percentile of 1,246 neurology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NourianzIstradefylline | 12 | $35,845 |
| XcopriCenobamate | 27 | $34,127 |
| RytaryCarbidopa/Levodopa | 68 | $30,447 |
| Keppra XrLevetiracetam | 21 | $14,629 |
| Pramipexole ErPramipexole Di-Hcl | 20 | $13,113 |
| Rasagiline Mesylate | 26 | $5,676 |
| SynthroidLevothyroxine Sodium | 14 | $1,828 |
| Gabapentin | 39 | $1,139 |
| Pregabalin | 62 | $1,113 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 16 | $846 |
| Zonisamide | 29 | $762 |
| Levetiracetam | 32 | $761 |
| Divalproex Sodium ErDivalproex Sodium | 15 | $476 |
| Quetiapine Fumarate | 18 | $469 |
| Lamotrigine | 29 | $444 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Kyowa Kirin, Inc.Nourianz | $158 | $35,84512 claims |
| SK Life Science, Inc.Xcopri | $1,166 | $34,12727 claims |
| Amneal Pharmaceuticals LLCRytary | $543 | $30,44768 claims |
| AbbVieSynthroid | $285 | $1,82814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,246 neurology providers in Texas.
Other neurology in Houston
- Jamshid LotfiHouston$6M
- Nazanin MajdHouston$5.9M
- Aziz ShaibaniHouston$5.5M
- John LindseyHouston$3.9M
- Joseph KassHouston$3.7M
- William OndoHouston$3.1M
- Vinay PuduvalliHouston$2.5M
- Erin Furr-StimmingHouston$2.1M
- Arjun TarakadHouston$2M
- Mazen DimachkieHouston$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.